These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
169 related items for PubMed ID: 6209194
21. [Therapy of urticaria with H1 and H2 antihistaminics. Results of clinical and experimental studies]. Paul E, Pfeffer M, Bödeker RH. Z Hautkr; 1987 Mar 01; 62(5):401-2, 405-6. PubMed ID: 2884788 [Abstract] [Full Text] [Related]
22. Comparative study of the efficacy and tolerance of terfenadine and clemastine in patients with seasonal allergic rhinitis. Gastpar H, Dieterich HA. Arzneimittelforschung; 1982 Mar 01; 32(9a):1211-3. PubMed ID: 6129872 [Abstract] [Full Text] [Related]
23. Prophylaxis of seasonal allergic rhinitis with a new antihistaminic drug. Gastpar H, Dieterich HA. Arzneimittelforschung; 1982 Mar 01; 32(9a):1209-11. PubMed ID: 6129871 [Abstract] [Full Text] [Related]
24. Treatment of chronic urticaria with terfenadine and ranitidine. A randomized double-blind study in 45 patients. Paul E, Bödeker RH. Eur J Clin Pharmacol; 1986 Mar 01; 31(3):277-80. PubMed ID: 2878811 [Abstract] [Full Text] [Related]
25. Rupatadine in the treatment of chronic idiopathic urticaria: a double-blind, randomized, placebo-controlled multicentre study. Gimenez-Arnau A, Pujol RM, Ianosi S, Kaszuba A, Malbran A, Poop G, Donado E, Perez I, Izquierdo I, Arnaiz E, Rupatadine Urticaria Study Group. Allergy; 2007 May 01; 62(5):539-46. PubMed ID: 17441794 [Abstract] [Full Text] [Related]
26. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. Dubertret L, Zalupca L, Cristodoulo T, Benea V, Medina I, Fantin S, Lahfa M, Pérez I, Izquierdo I, Arnaiz E. Eur J Dermatol; 2007 May 01; 17(3):223-8. PubMed ID: 17478385 [Abstract] [Full Text] [Related]
27. Clinical effectiveness and safety of cetirizine versus rupatadine in chronic spontaneous urticaria: a randomized, double-blind, 6-week trial. Dakhale GN, Shinde AT, Mahatme MS, Hiware SK, Mishra DB, Mukhi JI, Salve AM. Int J Dermatol; 2014 May 01; 53(5):643-9. PubMed ID: 24320728 [Abstract] [Full Text] [Related]
30. The use of a responder analysis to identify clinically meaningful differences in chronic urticaria patients following placebo- controlled treatment with rupatadine 10 and 20 mg. Giménez-Arnau A, Izquierdo I, Maurer M. J Eur Acad Dermatol Venereol; 2009 Sep 01; 23(9):1088-91. PubMed ID: 19453774 [Abstract] [Full Text] [Related]
37. A placebo-controlled comparative study of Dimotane LA against Optimine in the treatment of chronic urticaria with or without dermographism. Sim-Davis D, Templeton JS. Br J Clin Pract; 1983 Jan 01; 37(7-8):253-8. PubMed ID: 6136296 [No Abstract] [Full Text] [Related]
38. Terfenadine (single or associated) treatment of adverse reactions to foods. Ciprandi G, Scordamaglia A, Ruffoni S, Pizzorno G, Ferrini O, Canonica GW. Allergol Immunopathol (Madr); 1987 Jan 01; 15(4):201-3. PubMed ID: 3120557 [Abstract] [Full Text] [Related]
39. Effects of loratadine (SCH 29851) in suppression of histamine-induced skin wheals. Kassem N, Roman I, Gural R, Dyer JG, Robillard N. Ann Allergy; 1988 Jun 01; 60(6):505-7. PubMed ID: 2968060 [Abstract] [Full Text] [Related]